Brevan Howard Capital Management LP Harmony Biosciences Holdings, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 28,362 shares of HRMY stock, worth $907,016. This represents 0.01% of its overall portfolio holdings.
Number of Shares
28,362
Previous 43,329
34.54%
Holding current value
$907,016
Previous $1.49 Million
36.85%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
278Shares Held
44.8MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$212 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$187 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$50.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$41.2 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.89B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...